Respiratory physician Lutz Beckert considers chronic obstructive pulmonary disease management, including the prevention of COPD, the importance of smoking cessation and pulmonary rehabilitation, and the lifesaving potential of addressing treatable traits. He also discusses the logic of inhaler therapy, moving from single therapy to dual and triple therapy when indicated, as well as other aspects of management
MeNZB – a gift we didn’t expect, and are still unwrapping
Tuesday 26 September 2017, 01:27 PM

A gift: the MeNZB vaccine was more broadly effective than expected
The 2004–2008 MeNZB meningococcal vaccine programme reached over one million adolescents; an epidemic was curtailed and a legacy set up for reduced rates of gonorrhoea
By Helen Petousis-Harris
The second most common bacterial sexually transmitted disease, gonorrhoea, has officially become a superbug, with multidr
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.
References
1. Petousis-Harris H, Paynter J, Morgan J et al. Effectiveness of a group B outer membrane vesicle meningococcal vaccine against gonorrhoea in New Zealand: a retrospective case-control study. Lancet 7 Jul 2017. doi: 10.1016/S0140-6736(17)31449-6. [Epub]
2. Pérez O, Campo JD, Cuello M et al. Mucosal approaches in Neisseria vaccinology. VacciMonitor 2009;18(2):53–55.